Skip to main content
CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
2.770
-0.210 (-7.05%)
Mar 31, 2025, 1:15 PM EDT - Market open

CureVac Revenue

CureVac had revenue of 14.44M EUR in the quarter ending June 30, 2024, with 90.47% growth. This brings the company's revenue in the last twelve months to 65.86M, up 75.12% year-over-year. In the year 2023, CureVac had annual revenue of 53.76M, down -20.26%.

Revenue (ttm)
65.86M EUR
Revenue Growth
+75.12%
P/S Ratio
9.47
Revenue / Employee
56,194 EUR
Employees
1,172
Market Cap
621.35M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202353.76M-13.66M-20.26%
Dec 31, 202267.42M-35.57M-34.54%
Dec 31, 2021102.99M54.12M110.74%
Dec 31, 202048.87M31.46M180.61%
Dec 31, 201917.42M4.55M35.31%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

CVAC News

More News